Changchung Cheng is a notable inventor based in Dongguan, China. He has made significant contributions to the field of medicine through his innovative patents. With a total of six patents to his name, Cheng has focused on developing pharmaceutical compounds that address various medical conditions.

Latest Patents

Cheng's latest patents include a "Salt of substituted urea derivative and use thereof in medicine." This invention involves a salt of a substituted urea derivative and its application in the pharmaceutical field. It also encompasses a pharmaceutical composition containing the salt, which is intended for treating, remitting, or preventing disorders related to tyrosine kinase activity. Another significant patent is for "Tricyclic compounds and uses thereof in medicine." This invention relates to novel tricyclic compounds that can bind to FXR and act as modulators. The patent outlines the uses of these compounds for treating diseases mediated by FXR, along with a pharmaceutical composition and method of treatment.

Career Highlights

Throughout his career, Cheng has worked with prominent companies in the pharmaceutical industry. Notable among these are Sunshine Lake Pharma Co., Ltd. and North & South Brother Pharmacy Investment Company Limited. His work in these organizations has contributed to the advancement of pharmaceutical research and development.

Collaborations

Cheng has collaborated with several professionals in his field, including Yingjun Zhang and Bing Liu. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the impact of his inventions.

Conclusion

Changchung Cheng is a distinguished inventor whose work in pharmaceutical compounds has the potential to significantly improve medical treatments. His innovative patents reflect his commitment to advancing healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.